Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 23, 2026 0.8622
October 22, 2026 0.8902
October 21, 2026 0.9718
October 20, 2026 0.9505
October 19, 2026 0.9522
October 16, 2026 0.9974
October 15, 2026 1.079
October 14, 2026 1.010
October 13, 2026 1.112
October 12, 2026 1.182
October 09, 2026 1.176
October 08, 2026 1.200
October 07, 2026 1.211
October 06, 2026 1.208
October 05, 2026 1.339
October 02, 2026 1.340
October 01, 2026 1.348
September 30, 2026 1.398
September 29, 2026 1.473
September 28, 2026 1.447
September 25, 2026 1.469
September 24, 2026 1.508
September 23, 2026 1.582
September 22, 2026 1.520
September 21, 2026 1.501
Date Value
September 18, 2026 1.494
September 17, 2026 1.603
September 16, 2026 1.696
September 15, 2026 1.752
September 14, 2026 1.801
September 11, 2026 1.938
September 10, 2026 1.948
September 09, 2026 1.962
September 08, 2026 1.959
September 04, 2026 2.022
September 03, 2026 2.121
September 02, 2026 2.312
September 01, 2026 2.535
August 31, 2026 2.647
August 28, 2026 3.018
August 27, 2026 3.001
August 26, 2026 2.637
August 25, 2026 2.687
August 24, 2026 2.872
August 21, 2026 2.702
August 20, 2026 2.520
August 19, 2026 2.489
August 18, 2026 2.723
August 17, 2026 2.741
August 14, 2026 3.005

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 20.32
Anika Therapeutics, Inc. 2.088
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.376

Price to Book Value Related Metrics

Price 0.206
Earnings Yield -6.76K%
Market Cap 1.518M